Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt after a series of trial results have left investors feeling unsatisfied.

Rooted in the legacy of Sri Vasavi Thangamaaligai, a jewellery house serving customers since 1942 in Dindigul, Tamil Nadu, ...

Chandigarh: PGI's medical innovation, conceived and developed entirely in India, is set to redefine neuropathic pain ...

A class action lawsuit was filed against Novo Nordisk A/S (NVO) by Levi & Korsinsky on January 24, 2025. The plaintiffs ...

The crypto market never sleeps, and neither do the projects driving the next wave of blockchain innovation. With Arbitrum ...

Explore the ONEXSUGAR, a cutting-edge handheld gaming device with dual screens, Android versatility, and powerful Snapdragon ...

Space Marine 2 launched back in 2023, it felt like everyone and their mum were bisecting Tyranids in the Emperor's name.

In fintech, where every line of code has the potential to impact the financial ecosystem, one professional stands out for her ...

The slew of litigation filed by states’ attorneys in the USA challenging Trump’s executive orders on citizenship, federal ...

Empuraan sets new records with massive advance bookings, aiming to redefine Malayalam cinema’s box office benchmarks.

Bengal’s Most Stylish, Kolkata prepares for an evening where fashion becomes the beholder and personalities shine brighter ...